Fewer adolescents are consuming cannabis; among those who do, fewer are engaging in problematic use of the plant, according to newly published data in the Journal of the American Academy of Child & Adolescent Psychiatry.
Investigators at Washington University School of Medicine in St. Louis evaluated government survey data on adolescents’ self-reported drug use during the years 2002 to 2013. Over 216,000 adolescents ages 12 to 17 participated in the federally commissioned surveys.
Researchers reported that the percentage of respondents who said that they had used cannabis over the past year fell by ten percent during the study period. The number of adolescents reporting problems related to marijuana, such as engaging in habitual use of the plant, declined by 24 percent from 2002 to 2013.
The study’s lead author acknowledged that the declines in marijuana use and abuse were “substantial.”
The study’s findings are consistent with previous evaluations reporting decreased marijuana use and abuse by young people over the past decade and a half — a period of time during which numerous states have liberalized their marijuana policies.
An abstract of the new study, “Declining prevalence of marijuana use disorders among adolescents in the United States, 2002 to 2013,” appears online here.
Solid majorities of voters in the swing states of Florida, Ohio, and Pennsylvania support the legalization of marijuana for adult use, and super-majorities in Florida and Ohio support efforts to medicalize the plant, according to polling data provided today by Quinnipiac University.
Fifty-six percent of Florida voters believe that state law ought to allow “adults to legally possess for personal use small amounts of marijuana.” Only majorities of self-identified Republicans and respondents over the age of 65 oppose legalization.
With regard to the question of permitting medical cannabis access, 80 percent of Floridians say that “they will vote for a constitutional amendment this November allowing for medical marijuana.” The 2016 ballot measure, entitled the “Use of Marijuana for Debilitating Conditions,” will appear before voters as Amendment 2. Passage of the amendment would permit qualified patients to possess and obtain cannabis from state-licensed facilities. Support for the measure is over 70 percent among every party, gender, education, age and ethnic group measured, Quinnipiac reported.
In Ohio, 52 percent of voters endorse “allowing adults to legally possess small amounts of marijuana for personal use,” and 90 percent support “legalizing the use of medical marijuana.” Legislation to permit the limited use of non-herbal cannabis formulations by qualified patients was recently passed by Ohio House lawmakers and awaits further action by the Senate. A separate, more comprehensive medical marijuana measure sponsored by the Marijuana Policy Project may appear on the November 2016 Ohio ballot.
In Pennsylvania, voters support by a margin of 57 percent to 39 percent the notion of “allowing adults to legally possess small amounts of marijuana for personal use.” As in Florida, only Republicans and voters over 65 years old expressed majority opposition to legalization. Quinnipiac pollsters did not ask voters to provide their opinions with regard to medicinal cannabis, which state lawmakers just legalized in April.
The Quinnipiac survey results are similar to those of other recent national polls, such as those by reported by CBS, Gallup, and Pew, finding that a majority of Americans now support ending marijuana prohibition.
Alabama: Governor Robert Bentley has signed legislation, House Bill 61, to protect qualified patients eligible for CBD therapy under a physician’s authorization from criminal prosecution. The measure, known as ‘Leni’s Law’, allows qualified patients to possess CBD preparations containing up to three percent THC. The new law takes effect June 1st, 2016.
Colorado: House and Senate lawmakers have overwhelmingly approved legislation, House Bill 1373, to permit qualified patients access to the use formulations of medical cannabis while on school grounds.The measure now awaits action by Gov. John Hickenlooper, who indicated that he would sign the measure into law. “My son, if he needed medical marijuana and he needed it during the day while he was in school, I’d want him to have that opportunity,” Hickenlooper said.
Connecticut: House and Senate lawmakers have approved legislation expanding patients’ access to the state’s medicinal cannabis program. House Bill 5450 permits qualifying patients under the age of 18 to possess and consume medical cannabis preparations and it also expands the list of qualifying illnesses eligible for cannabis therapy. Other provisions in the bill seek to establish a statewide clinical research program, and protect nurses from criminal, civil, or disciplinary sanction if they choose to administer marijuana to a qualifying patient in a hospital setting. The measure now awaits action by Governor Dannel Malloy. #TakeAction
Hawaii: Legislation is pending before Governor David Ige to expand medical cannabis access and dispensing. The measure expands the pool of practitioners who may legally recommend cannabis therapy to include advanced nurse practitioners. Separate provisions in the bill remove the prohibition on Sunday dispensary sales and on the possession of marijuana-related paraphernalia by qualified patients.It also permits the transportation of medical marijuana across islands for the purposes of laboratory testing. #TakeAction
Kansas: House and Senate lawmakers have signed off on sentencing reform legislation, House Bill 2049, that reduces criminal penalties for first-time marijuana possession offenses from a Class A misdemeanor (punishable by up to one year incarceration and a $2,500 fine) to a Class B misdemeanor (punishable by no more than six months in jail and a $1,000 fine). Second convictions will no longer be classified as a felony offense. The bill now heads to Gov. Brownback’s desk, and will become law if he does not veto it within 10 days. #TakeAction
Louisiana: Senate legislation to fix and expand the state’s dormant medical marijuana law received a boost this week after a House Committee amended and passed the measure. Senate Bill 271 seeks to change the language of existing law so that physicians may ‘recommend’ rather than prescribe cannabis therapy. Under federal law, physicians cannot legally ‘prescribe’ cannabis or any schedule I substance. It also expands the pool of patients eligible to receive marijuana therapy. The legislation is scheduled to be heard by members of the House Health and Welfare Committee next week. #TakeAction
New Hampshire: Members of the House Criminal Justice and Public Safety Committee voted 12 to 7 this week to amend Senate-backed sentencing reform legislation, Senate Bill 498, to also include provisions decriminalizing minor, first-time marijuana possession offenses. The amended language would make first-time offenses a civil violation rather than a criminal offense. The civil penalty would be limited to a fine only: no arrest, prosecution, or criminal record. Subsequent offenses would continue to be classified as misdemeanors. #TakeAction
Oklahoma: House and Senate lawmakers have approved legislation, HB 2835, to expand the pool of patients eligible to possess cannabidiol under a physician’s authorization. As amended, House Bill 2835 would include legal protections to the following patient groups: those with “spasticity due to multiple sclerosis or due to paraplegia, intractable nausea and vomiting, appetite stimulation with chronic wasting diseases.” The measure also removes the age requirement limitation from existing law so that adults with various forms of epilepsy are eligible for CBD therapy. The measure now awaits action from Gov. Mary Fallin. #TakeAction
Pennsylvania: Representative Ed Gainey is seeking co-sponsors for soon-to-be introduced legislation that would amend minor marijuana possession offenses to a non-criminal offense. Despite both local and nationwide progress on the issue of cannabis prohibition, Pennsylvania continues to charge over 18,000 individuals each year with minor possessory offenses. Please urge your House member to sign on as a co-sponsor to this important legislation. #TakeAction
Rhode Island: Members of the Senate Judiciary Committee are scheduled to consider SB 2420, legislation to regulate the commercial production and retail sale of marijuana to those over the age of 21, on Tuesday, May 10th. Adults would be permitted to purchase and possess up to one ounce of marijuana. It also permits adults to cultivate up to two marijuana plants (no more than 1 mature) at home for non-commercial purposes. You can read the full text of this proposal here. #TakeAction
Tennessee: Two marijuana related measures became law recently in Tennessee. The first permits for the licensed cultivation of industrial hemp when “grown by an institution of higher education in this state that offers a baccalaureate or post-graduate level program of study in agricultural sciences.” The second, amends third-time marijuana possession offenses from a Class E felony, punishable by up to six years in prison, to a misdemeanor offense, punishable by no more than one year in jail. The new sentencing penalties take effect on July 1, 2016.
For a summary of all pending marijuana legislation, be sure to check out our full #TakeAction center!
And don’t forget to register to attend NORML’s 2016 Congressional Lobby Day in Washington D.C. May 23rd and 24th! We have just recently confirmedthree members of Congress’ ability to address our group on Capitol Hill so you won’t want to miss it!
The Secretary of State determined today that initiative proponents, The Campaign to Regulate Marijuana Like Alcohol, gathered a sufficient number of signatures from registered voters to qualify the measure for the November ballot. The office had previously attempted to invalidate a significant portion of proponents’ signatures, but that effort was rejected by the courts earlier this month.
If enacted by voters in November, the measure would allow adults to legally possess up to two and one-half ounces of marijuana and to cultivate marijuana (up to six mature plants and the entire yields of said plants) for their own personal use. The measure would also establish licensing for the commercial production and retail sale of cannabis. Retail sales of cannabis would be subject to a ten percent sales tax. Non-commercial transactions and/or retail sales involving medical cannabis would not be subject to taxation. You can read the full text of the proposed initiative here.
Maine is one of a number of states — including Arizona, California, Massachusetts, Michigan, and Nevada — where voters are expected to decide this fall on legalizing the adult use of cannabis. According to statewide survey data provided by the Maine People’s Resource Center, nearly 54 percent of likely Maine voters would approve the initiative if the election were held today. Only 42 percent of respondents said they would oppose it.
Rates of prescription opioid abuse are significantly lower in jurisdictions that permit medical marijuana access, according to data reported by Castlight Health, an employee health benefits platform provider.
Investigators assessed anonymous prescription reporting data from over one million employees between the years 2011 and 2015.
In states that did not permit medical marijuana access, 5.4 percent of individuals with an opioid prescription qualified as abusers of the drug. (The study’s authors defined “abuse” as opioid use by an individual who was not receiving palliative care, who received greater than a 90-day cumulative supply of opioids, and received an opioid prescription from four or more providers.) By contrast, only 2.8 percent of individuals with an opioid prescription living in medical marijuana states met the criteria.
The findings are similar to those reported by the RAND Corporation in 2015, which determined, “[S]tates permitting medical marijuana dispensaries experience a relative decrease in both opioid addictions and opioid overdose deaths compared to states that do not.”
Data published in 2014 in the Journal of the American Medical Association (JAMA) Internal Medicine also reported that the enactment of statewide medicinal marijuana laws is associated with significantly lower state-level opioid overdose mortality rates, finding, “States with medical cannabis laws had a 24.8 percent lower mean annual opioid overdose mortality rate compared with states without medical cannabis laws.”
Full text of the new study, “The opioid crisis in America’s workforce,” appears online here.